verapamil has been researched along with Keloid in 33 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Keloid: A sharply elevated, irregularly shaped, progressively enlarging scar resulting from formation of excessive amounts of collagen in the dermis during connective tissue repair. It is differentiated from a hypertrophic scar (CICATRIX, HYPERTROPHIC) in that the former does not spread to surrounding tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These findings suggest that the combination of verapamil and triamcinolone provides a more effective treatment for keloids, thereby highlighting the potential of verapamil in scar reduction." | 9.69 | Comparing intralesional triamcinolone and verapamil-triamcinolone injections in keloids: A single-blinded randomised clinical trial. ( Esmailzadeh, M; Hadadi, R; Haghani-Dogahe, Z; Mobayen, M, 2023) |
| "Concerning the treatment of keloids and hypertrophic scars, TAC was more effective than verapamil for improving vascularity; TAC was superior to verapamil in improving height within 9 weeks of treatment; TAC produced superior result for improving pliability within 18 weeks of treatment, whereas verapamil produced superior result between 18 and 24 weeks of treatment." | 9.41 | Efficacy and Safety of Verapamil Versus Triamcinolone Acetonide in Treating Keloids and Hypertrophic Scars: A Systematic Review and Meta-Analysis. ( Li, X; Zhang, W, 2023) |
| "This is a prospective, randomized study of intralesional injection of verapamil and triamcinolone in keloids conducted in the Burns and Plastic unit of a tertiary hospital." | 9.41 | A comparison of intralesional verapamil and triamcinolone monotherapy in the treatment of keloids in an African population. ( Belie, MF; Belie, O; Mofikoya, BO; T Omidiji, OA; Ugburo, AO, 2021) |
| "Our results did not support verapamil's capability in treatment of keloid nor hypertrophic scars." | 9.27 | Comparison of intralesional verapamil versus intralesional corticosteroids in treatment of keloids and hypertrophic scars: A randomized controlled trial. ( Abedini, R; Mahmoudi, HR; Nasimi, M; Sasani, P; Shadlou, Z; Teymourpour, A, 2018) |
| "A double-blind randomized controlled trial with a paired split-scar design compared verapamil, an L-type Ca2+ channel antagonist, and triamcinolone for prevention of keloid recurrence after excision." | 9.22 | Verapamil is Less Effective than Triamcinolone for Prevention of Keloid Scar Recurrence After Excision in a Randomized Controlled Trial. ( Alghamdi, M; Danielsen, PL; Fear, MW; Gankande, TU; Hool, LC; Manzur, M; Rea, SM; Stevenson, AW; Viola, HM; Wallace, HJ; Wood, FM, 2016) |
| "The aim of this study was to conduct a meta-analysis of the effectiveness and safety of verapamil and TAC in the treatment of HSs and keloids." | 9.12 | Comparing the Efficacy and Safety of Intralesional Verapamil With Intralesional Triamcinolone Acetonide in Treatment of Hypertrophic Scars and Keloids: A Meta-Analysis of Randomized Controlled Trials. ( Bi, H; Gu, L; Qin, Z; Wang, P; Wang, Q, 2021) |
| "TAC may be beneficial for the short-term treatment of hypertrophic scars and keloids; however, 5-FU, 5-FU+TAC, and verapamil may produce superior results for medium- and long-term treatments." | 9.12 | The safety and efficacy of intralesional triamcinolone acetonide for keloids and hypertrophic scars: A systematic review and meta-analysis. ( Li, Y; Wei, X; Zhuang, Z, 2021) |
| "These findings suggest that verapamil hydrochloride is an effective tool for the prevention and therapy of keloids." | 9.10 | Prevention and treatment of keloids with intralesional verapamil. ( Baroni, A; Brongo, S; D'Andrea, F; Ferraro, G, 2002) |
| "It appears that TAC is more effective than verapamil for improving scar pliability and vascularity in keloids and hypertrophic scars after 3 weeks of treatment." | 9.05 | The Safety and Efficacy of Intralesional Verapamil Versus Intralesional Triamcinolone Acetonide for Keloids and Hypertrophic Scars: A Systematic Review and Meta-analysis. ( Fu, ZH; Guo, GH; Jiang, ZY; Liao, XC; Liu, MZ; Min, DH, 2020) |
| "Thirty-one patients with 43 keloids were treated with IL verapamil at 3-week intervals until reaching complete flattening of the lesion or for a maximum of 6 sessions." | 8.02 | Intralesional verapamil in the treatment of keloids: A clinical, histopathological, and immunohistochemical study. ( Abou-Taleb, DAE; Badary, DM, 2021) |
| "Combined fractional CO2 laser and topical 5-FU or verapamil hydrochloride offer a safe therapy for HTSs and keloids." | 7.91 | The Efficacy of Combining Fractional Carbon Dioxide Laser With Verapamil Hydrochloride or 5-Fluorouracil in the Treatment of Hypertrophic Scars and Keloids: A Clinical and Immunohistochemical Study. ( Abd El Azez, TA; Abdel Rahman, SH; Hussein, MS; Sabry, HH; Sanad, RR, 2019) |
| "Keloids and hypertrophic scars are harmful to physical and psychological health." | 6.72 | Comparative efficacy and safety of verapamil and triamcinolone in keloid and hypertrophic scar treatment: a meta-analysis. ( An, P; Kuang, J; Li, W, 2021) |
| " Although triamcinolone acetonide (TAC) is one of the most common and effective treatments for keloids and hypertrophic scars, TAC is not effective in some patients, and some may even experience adverse outcomes." | 6.66 | Efficacy and safety of verapamil vs triamcinolone acetonide for keloids and hypertrophic scars: A systematic review and meta-analysis. ( Deng, Z; Liu, L; Liu, R; Yang, B; Zhao, X, 2020) |
| "These findings suggest that the combination of verapamil and triamcinolone provides a more effective treatment for keloids, thereby highlighting the potential of verapamil in scar reduction." | 5.69 | Comparing intralesional triamcinolone and verapamil-triamcinolone injections in keloids: A single-blinded randomised clinical trial. ( Esmailzadeh, M; Hadadi, R; Haghani-Dogahe, Z; Mobayen, M, 2023) |
| "Verapamil has shown a great potential in the management of keloid and hypertrophic scars." | 5.43 | Role of verapamil in preventing and treating hypertrophic scars and keloids. ( Cen, Y; Chen, J; Li, Z; Mao, Y; Wang, R; Zhang, Z, 2016) |
| "Concerning the treatment of keloids and hypertrophic scars, TAC was more effective than verapamil for improving vascularity; TAC was superior to verapamil in improving height within 9 weeks of treatment; TAC produced superior result for improving pliability within 18 weeks of treatment, whereas verapamil produced superior result between 18 and 24 weeks of treatment." | 5.41 | Efficacy and Safety of Verapamil Versus Triamcinolone Acetonide in Treating Keloids and Hypertrophic Scars: A Systematic Review and Meta-Analysis. ( Li, X; Zhang, W, 2023) |
| "This is a prospective, randomized study of intralesional injection of verapamil and triamcinolone in keloids conducted in the Burns and Plastic unit of a tertiary hospital." | 5.41 | A comparison of intralesional verapamil and triamcinolone monotherapy in the treatment of keloids in an African population. ( Belie, MF; Belie, O; Mofikoya, BO; T Omidiji, OA; Ugburo, AO, 2021) |
| "Our results did not support verapamil's capability in treatment of keloid nor hypertrophic scars." | 5.27 | Comparison of intralesional verapamil versus intralesional corticosteroids in treatment of keloids and hypertrophic scars: A randomized controlled trial. ( Abedini, R; Mahmoudi, HR; Nasimi, M; Sasani, P; Shadlou, Z; Teymourpour, A, 2018) |
| "Intralesional triamcinolone acetonide, intralesional triamcinolone acetonide with hyaluronidase, and intralesional radiofrequency with triamcinolone acetonide are effective modalities for the treatment of keloids." | 5.27 | A comparative study of various modalities in the treatment of keloids. ( Aggarwal, A; Raghukumar, S; Ravikumar, BC; Vinay, KN; Yashovardhana, DP, 2018) |
| "A double-blind randomized controlled trial with a paired split-scar design compared verapamil, an L-type Ca2+ channel antagonist, and triamcinolone for prevention of keloid recurrence after excision." | 5.22 | Verapamil is Less Effective than Triamcinolone for Prevention of Keloid Scar Recurrence After Excision in a Randomized Controlled Trial. ( Alghamdi, M; Danielsen, PL; Fear, MW; Gankande, TU; Hool, LC; Manzur, M; Rea, SM; Stevenson, AW; Viola, HM; Wallace, HJ; Wood, FM, 2016) |
| "The aim of this study was to conduct a meta-analysis of the effectiveness and safety of verapamil and TAC in the treatment of HSs and keloids." | 5.12 | Comparing the Efficacy and Safety of Intralesional Verapamil With Intralesional Triamcinolone Acetonide in Treatment of Hypertrophic Scars and Keloids: A Meta-Analysis of Randomized Controlled Trials. ( Bi, H; Gu, L; Qin, Z; Wang, P; Wang, Q, 2021) |
| "TAC may be beneficial for the short-term treatment of hypertrophic scars and keloids; however, 5-FU, 5-FU+TAC, and verapamil may produce superior results for medium- and long-term treatments." | 5.12 | The safety and efficacy of intralesional triamcinolone acetonide for keloids and hypertrophic scars: A systematic review and meta-analysis. ( Li, Y; Wei, X; Zhuang, Z, 2021) |
| "These findings suggest that verapamil hydrochloride is an effective tool for the prevention and therapy of keloids." | 5.10 | Prevention and treatment of keloids with intralesional verapamil. ( Baroni, A; Brongo, S; D'Andrea, F; Ferraro, G, 2002) |
| "It appears that TAC is more effective than verapamil for improving scar pliability and vascularity in keloids and hypertrophic scars after 3 weeks of treatment." | 5.05 | The Safety and Efficacy of Intralesional Verapamil Versus Intralesional Triamcinolone Acetonide for Keloids and Hypertrophic Scars: A Systematic Review and Meta-analysis. ( Fu, ZH; Guo, GH; Jiang, ZY; Liao, XC; Liu, MZ; Min, DH, 2020) |
| "Intralesional triamcinolone is a gold standard in treating the keloids in comparison with its effectiveness versus intralesional 5-fluorouracil intralesional verapamil and intralesional platelet-rich plasma." | 4.12 | Assessment of various intralesional injections in keloid: comparative analysis. ( Albalat, W; Khattab, F; Nabil, S, 2022) |
| "Thirty-one patients with 43 keloids were treated with IL verapamil at 3-week intervals until reaching complete flattening of the lesion or for a maximum of 6 sessions." | 4.02 | Intralesional verapamil in the treatment of keloids: A clinical, histopathological, and immunohistochemical study. ( Abou-Taleb, DAE; Badary, DM, 2021) |
| "Combined fractional CO2 laser and topical 5-FU or verapamil hydrochloride offer a safe therapy for HTSs and keloids." | 3.91 | The Efficacy of Combining Fractional Carbon Dioxide Laser With Verapamil Hydrochloride or 5-Fluorouracil in the Treatment of Hypertrophic Scars and Keloids: A Clinical and Immunohistochemical Study. ( Abd El Azez, TA; Abdel Rahman, SH; Hussein, MS; Sabry, HH; Sanad, RR, 2019) |
| "Keloids are pathologic scars that pose a significant functional and cosmetic burden." | 3.01 | Keloid treatments: an evidence-based systematic review of recent advances. ( Kundu, RV; Kwan, KR; Miller, CH; Pontes, D; Poondru, S; Walsh, LA; Wu, E, 2023) |
| "Different approaches are used aiming to improve these scars, including intralesional corticosteroids, surgery and more recently, laser therapy." | 2.82 | Laser therapy for treating hypertrophic and keloid scars. ( da Silva, CA; da Silva, EM; Kuczynski, U; Leszczynski, R; Pinto, ACPN, 2022) |
| "Keloids and hypertrophic scars are harmful to physical and psychological health." | 2.72 | Comparative efficacy and safety of verapamil and triamcinolone in keloid and hypertrophic scar treatment: a meta-analysis. ( An, P; Kuang, J; Li, W, 2021) |
| " Although triamcinolone acetonide (TAC) is one of the most common and effective treatments for keloids and hypertrophic scars, TAC is not effective in some patients, and some may even experience adverse outcomes." | 2.66 | Efficacy and safety of verapamil vs triamcinolone acetonide for keloids and hypertrophic scars: A systematic review and meta-analysis. ( Deng, Z; Liu, L; Liu, R; Yang, B; Zhao, X, 2020) |
| "To provide a comprehensive evidence-based review of current evidence on mechanism of action, efficacy, and adverse events of calcium antagonists in treatment of hypertrophic scars and keloids." | 2.52 | Mechanism of Action, Efficacy, and Adverse Events of Calcium Antagonists in Hypertrophic Scars and Keloids: A Systematic Review. ( Piatkowski de Grzymala, A; van der Hulst, R; Verhiel, S, 2015) |
| "Keloids are special type of skin lesions arising from sites of previous trauma." | 2.43 | [Therapeutic problems connected with keloid treatment--new treatment possibilities]. ( Brudnik, U; Podolec-Rubiś, M; Wojas-Pelc, A, 2006) |
| "The formation of hypertrophic scaring (HSc) is an abnormal wound-healing response." | 1.46 | A Comparison of Gene Expression of Decorin and MMP13 in Hypertrophic Scars Treated With Calcium Channel Blocker, Steroid, and Interferon: A Human-Scar-Carrying Animal Model Study. ( Chuang, SS; Hsiao, YC; Yang, JY; Yang, SY, 2017) |
| "Verapamil has shown a great potential in the management of keloid and hypertrophic scars." | 1.43 | Role of verapamil in preventing and treating hypertrophic scars and keloids. ( Cen, Y; Chen, J; Li, Z; Mao, Y; Wang, R; Zhang, Z, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.03) | 18.2507 |
| 2000's | 5 (15.15) | 29.6817 |
| 2010's | 12 (36.36) | 24.3611 |
| 2020's | 15 (45.45) | 2.80 |
| Authors | Studies |
|---|---|
| Leszczynski, R | 1 |
| da Silva, CA | 1 |
| Pinto, ACPN | 1 |
| Kuczynski, U | 1 |
| da Silva, EM | 1 |
| Zhang, W | 1 |
| Li, X | 2 |
| Walsh, LA | 1 |
| Wu, E | 1 |
| Pontes, D | 1 |
| Kwan, KR | 1 |
| Poondru, S | 1 |
| Miller, CH | 1 |
| Kundu, RV | 1 |
| Haghani-Dogahe, Z | 1 |
| Hadadi, R | 1 |
| Esmailzadeh, M | 1 |
| Mobayen, M | 1 |
| Teplyi, V | 1 |
| Grebchenko, K | 1 |
| Jiang, ZY | 1 |
| Liao, XC | 1 |
| Liu, MZ | 1 |
| Fu, ZH | 1 |
| Min, DH | 1 |
| Guo, GH | 1 |
| Liu, R | 1 |
| Yang, B | 1 |
| Deng, Z | 1 |
| Liu, L | 1 |
| Zhao, X | 1 |
| Abou-Taleb, DAE | 1 |
| Badary, DM | 1 |
| Ahuja, RB | 2 |
| Chatterjee, P | 2 |
| Wang, P | 2 |
| Gu, L | 2 |
| Bi, H | 2 |
| Qin, Z | 2 |
| Wang, Q | 1 |
| Walsh, M | 1 |
| Zhuang, Z | 1 |
| Li, Y | 1 |
| Wei, X | 1 |
| Albalat, W | 1 |
| Nabil, S | 1 |
| Khattab, F | 1 |
| Kuang, J | 1 |
| An, P | 1 |
| Li, W | 1 |
| Belie, O | 1 |
| Ugburo, AO | 1 |
| Mofikoya, BO | 1 |
| T Omidiji, OA | 1 |
| Belie, MF | 1 |
| Abedini, R | 1 |
| Sasani, P | 1 |
| Mahmoudi, HR | 1 |
| Nasimi, M | 1 |
| Teymourpour, A | 1 |
| Shadlou, Z | 1 |
| Aggarwal, A | 1 |
| Ravikumar, BC | 1 |
| Vinay, KN | 1 |
| Raghukumar, S | 1 |
| Yashovardhana, DP | 1 |
| Sabry, HH | 1 |
| Abdel Rahman, SH | 1 |
| Hussein, MS | 1 |
| Sanad, RR | 1 |
| Abd El Azez, TA | 1 |
| Ledon, JA | 1 |
| Savas, J | 1 |
| Franca, K | 1 |
| Chacon, A | 1 |
| Nouri, K | 1 |
| Boggio, RF | 1 |
| Boggio, LF | 1 |
| Galvão, BL | 1 |
| Machado-Santelli, GM | 1 |
| Wang, R | 1 |
| Mao, Y | 1 |
| Zhang, Z | 1 |
| Li, Z | 1 |
| Chen, J | 1 |
| Cen, Y | 1 |
| Verhiel, S | 1 |
| Piatkowski de Grzymala, A | 1 |
| van der Hulst, R | 1 |
| Danielsen, PL | 1 |
| Rea, SM | 1 |
| Wood, FM | 1 |
| Fear, MW | 1 |
| Viola, HM | 1 |
| Hool, LC | 1 |
| Gankande, TU | 1 |
| Alghamdi, M | 1 |
| Stevenson, AW | 1 |
| Manzur, M | 1 |
| Wallace, HJ | 1 |
| Yang, SY | 1 |
| Yang, JY | 1 |
| Hsiao, YC | 1 |
| Chuang, SS | 1 |
| Alexandrescu, D | 1 |
| Fabi, S | 1 |
| Yeh, LC | 1 |
| Fitzpatrick, RE | 1 |
| Goldman, MP | 1 |
| Juckett, G | 1 |
| Hartman-Adams, H | 1 |
| Giugliano, G | 1 |
| Pasquali, D | 1 |
| Notaro, A | 1 |
| Brongo, S | 2 |
| Nicoletti, G | 1 |
| D'Andrea, F | 2 |
| Bellastella, A | 1 |
| Sinisi, AA | 1 |
| Skaria, AM | 1 |
| Brudnik, U | 1 |
| Podolec-Rubiś, M | 1 |
| Wojas-Pelc, A | 1 |
| Lawrence, WT | 1 |
| Ferraro, G | 1 |
| Baroni, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Intra-lesional ACE Inhibitor for Treatment of Hypertrophic Scars[NCT05259137] | Phase 2/Phase 3 | 30 participants (Anticipated) | Interventional | 2023-08-31 | Not yet recruiting | ||
| Assessing and Improving Patient Knowledge About Keloids[NCT01176877] | 40 participants (Actual) | Interventional | 2010-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
All subjects completed a written questionnaire to assess knowledge about keloid scars before an educational lecture about keloids, immediately after the educational lecture about keloids, and 3 months after the educational lecture about keloids. This written questionnaire to assess knowledge about keloid scars contained 19 questions related to risk factors for developing keloid scars, keloid scar prevention, and keloid scar treatment. A correct response to a question was awarded 1 point and all correct responses were summed to achieve a total score. Possible total score ranged from 0 to 19. A score of 0 is associated with worse knowledge about keloid scars and a score of 19 is associated with better knowledge about keloid scars. (NCT01176877)
Timeframe: immediately before and after a 5 minute educational lecture
| Intervention | score on a scale (Mean) | |
|---|---|---|
| Pre-educational lecture score | Immediate post-educational lecture score | |
| Keloid Scar | 12.9 | 18.3 |
All subjects completed a written questionnaire to assess knowledge about keloid scars before an educational lecture about keloids, immediately after the educational lecture about keloids, and 3 months after the educational lecture about keloids. This written questionnaire to assess knowledge about keloid scars contained 19 questions related to risk factors for developing keloid scars, keloid scar prevention, and keloid scar treatment. A correct response to a question was awarded 1 point and all correct responses were summed to achieve a total score. Possible total score ranged from 0 to 19. A score of 0 is associated with worse knowledge about keloid scars and a score of 19 is associated with better knowledge about keloid scars. (NCT01176877)
Timeframe: before and 3 months after a 5 minute educational lecture
| Intervention | score on a scale (Mean) | |
|---|---|---|
| Pre-educational lecture score | 3 months post-educational lecture score | |
| Keloid Scars | 13.2 | 16.8 |
13 reviews available for verapamil and Keloid
| Article | Year |
|---|---|
Laser therapy for treating hypertrophic and keloid scars.
Topics: Adrenal Cortex Hormones; Adult; Aluminum; Atrophy; Carbon Dioxide; Child; Cicatrix, Hypertrophic; Di | 2022 |
Efficacy and Safety of Verapamil Versus Triamcinolone Acetonide in Treating Keloids and Hypertrophic Scars: A Systematic Review and Meta-Analysis.
Topics: Cicatrix, Hypertrophic; Humans; Injections, Intralesional; Keloid; Randomized Controlled Trials as T | 2023 |
Keloid treatments: an evidence-based systematic review of recent advances.
Topics: Adrenal Cortex Hormones; Fluorouracil; Humans; Keloid; Prospective Studies; Treatment Outcome; Verap | 2023 |
The Safety and Efficacy of Intralesional Verapamil Versus Intralesional Triamcinolone Acetonide for Keloids and Hypertrophic Scars: A Systematic Review and Meta-analysis.
Topics: Calcium Channel Blockers; Cicatrix, Hypertrophic; Glucocorticoids; Humans; Injections, Intralesional | 2020 |
Efficacy and safety of verapamil vs triamcinolone acetonide for keloids and hypertrophic scars: A systematic review and meta-analysis.
Topics: Cicatrix, Hypertrophic; Humans; Injections, Intralesional; Keloid; Triamcinolone Acetonide; Verapami | 2020 |
Comparing the Efficacy and Safety of Intralesional Verapamil With Intralesional Triamcinolone Acetonide in Treatment of Hypertrophic Scars and Keloids: A Meta-Analysis of Randomized Controlled Trials.
Topics: Cicatrix, Hypertrophic; Humans; Injections, Intralesional; Keloid; Randomized Controlled Trials as T | 2021 |
The safety and efficacy of intralesional triamcinolone acetonide for keloids and hypertrophic scars: A systematic review and meta-analysis.
Topics: Atrophy; Burns; Cicatrix, Hypertrophic; Culture Media; Fluorouracil; Humans; Injections, Intralesion | 2021 |
Comparative efficacy and safety of verapamil and triamcinolone in keloid and hypertrophic scar treatment: a meta-analysis.
Topics: Cicatrix, Hypertrophic; Humans; Injections, Intralesional; Keloid; Treatment Outcome; Triamcinolone | 2021 |
Intralesional treatment for keloids and hypertrophic scars: a review.
Topics: Adrenal Cortex Hormones; Antibiotics, Antineoplastic; Antimetabolites; Bleomycin; Calcium Channel Bl | 2013 |
Mechanism of Action, Efficacy, and Adverse Events of Calcium Antagonists in Hypertrophic Scars and Keloids: A Systematic Review.
Topics: Calcium Channel Blockers; Cicatrix, Hypertrophic; Humans; Keloid; Verapamil | 2015 |
Comparative Results in Treatment of Keloids With Intralesional 5-FU/Kenalog, 5-FU/Verapamil, Enalapril Alone,Verapamil Alone, and Laser: A Case Report and Review of the Literature.
Topics: Adult; Drug Therapy, Combination; Enalapril; Fluorouracil; Humans; Injections, Intralesional; Keloid | 2016 |
Management of keloids and hypertrophic scars.
Topics: Bleomycin; Cicatrix, Hypertrophic; Cryotherapy; Fluorouracil; Glucocorticoids; Humans; Keloid; Recur | 2009 |
Management of keloids and hypertrophic scars.
Topics: Bleomycin; Cicatrix, Hypertrophic; Cryotherapy; Fluorouracil; Glucocorticoids; Humans; Keloid; Recur | 2009 |
Management of keloids and hypertrophic scars.
Topics: Bleomycin; Cicatrix, Hypertrophic; Cryotherapy; Fluorouracil; Glucocorticoids; Humans; Keloid; Recur | 2009 |
Management of keloids and hypertrophic scars.
Topics: Bleomycin; Cicatrix, Hypertrophic; Cryotherapy; Fluorouracil; Glucocorticoids; Humans; Keloid; Recur | 2009 |
[Therapeutic problems connected with keloid treatment--new treatment possibilities].
Topics: Cicatrix, Hypertrophic; Dermatologic Agents; Fibroblasts; Humans; Keloid; Mitomycin; Scleroderma, Lo | 2006 |
8 trials available for verapamil and Keloid
| Article | Year |
|---|---|
Comparing intralesional triamcinolone and verapamil-triamcinolone injections in keloids: A single-blinded randomised clinical trial.
Topics: Cicatrix, Hypertrophic; Glucocorticoids; Humans; Injections, Intralesional; Keloid; Treatment Outcom | 2023 |
THE USAGE OF RADIOFREQUENCY ABLATION FOR TREATMENT OF KELOIDS AND HYPERTROPHIC SCARS.
Topics: Adult; Catheter Ablation; Cicatrix, Hypertrophic; Combined Modality Therapy; Female; Fluorouracil; H | 2019 |
A comparison of intralesional verapamil and triamcinolone monotherapy in the treatment of keloids in an African population.
Topics: Glucocorticoids; Humans; Keloid; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Ve | 2021 |
Comparison of intralesional verapamil versus intralesional corticosteroids in treatment of keloids and hypertrophic scars: A randomized controlled trial.
Topics: Adolescent; Adult; Calcium Channel Blockers; Cicatrix, Hypertrophic; Factor Analysis, Statistical; F | 2018 |
A comparative study of various modalities in the treatment of keloids.
Topics: Adolescent; Adult; Antineoplastic Agents; Calcium Channel Blockers; Combined Modality Therapy; Drug | 2018 |
Comparative efficacy of intralesional verapamil hydrochloride and triamcinolone acetonide in hypertrophic scars and keloids.
Topics: Adolescent; Adult; Calcium Channel Blockers; Cicatrix, Hypertrophic; Female; Glucocorticoids; Humans | 2014 |
Verapamil is Less Effective than Triamcinolone for Prevention of Keloid Scar Recurrence After Excision in a Randomized Controlled Trial.
Topics: Adolescent; Adult; Cicatrix; Double-Blind Method; Female; Glucocorticoids; Humans; Injections, Intra | 2016 |
Prevention and treatment of keloids with intralesional verapamil.
Topics: Administration, Topical; Adult; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Inject | 2002 |
12 other studies available for verapamil and Keloid
| Article | Year |
|---|---|
Intralesional verapamil in the treatment of keloids: A clinical, histopathological, and immunohistochemical study.
Topics: Glucocorticoids; Humans; Injections, Intralesional; Keloid; Pain; Treatment Outcome; Verapamil | 2021 |
Response to Letter to the Editor: Comments on "Comparative efficacy of intralesional verapamil hydrochloride and triamcinolone acetonide in hypertrophic scars and keloids".
Topics: Burns; Cicatrix, Hypertrophic; Humans; Injections, Intralesional; Keloid; Triamcinolone Acetonide; V | 2020 |
Comments on "Comparative efficacy of intralesional verapamil hydrochloride and triamcinolone acetonide in hypertrophic scars and keloids".
Topics: Burns; Cicatrix, Hypertrophic; Humans; Injections, Intralesional; Keloid; Triamcinolone Acetonide; V | 2020 |
Commentary on: Comparing the Efficacy and Safety of Intralesional Verapamil With Intralesional Triamcinolone Acetonide in Treatment of Hypertrophic Scars and Keloids: A Meta-Analysis of Randomized Controlled Trials.
Topics: Cicatrix, Hypertrophic; Humans; Injections, Intralesional; Keloid; Randomized Controlled Trials as T | 2021 |
Assessment of various intralesional injections in keloid: comparative analysis.
Topics: Fluorouracil; Humans; Injections, Intralesional; Keloid; Treatment Outcome; Triamcinolone Acetonide; | 2022 |
The Efficacy of Combining Fractional Carbon Dioxide Laser With Verapamil Hydrochloride or 5-Fluorouracil in the Treatment of Hypertrophic Scars and Keloids: A Clinical and Immunohistochemical Study.
Topics: Administration, Topical; Cicatrix, Hypertrophic; Combined Modality Therapy; Dose Fractionation, Radi | 2019 |
Topical verapamil as a scar modulator.
Topics: Abdominoplasty; Administration, Topical; Adult; Aged; Calcium Channel Blockers; Cicatrix, Hypertroph | 2014 |
Role of verapamil in preventing and treating hypertrophic scars and keloids.
Topics: Cicatrix, Hypertrophic; Databases, Factual; Humans; Keloid; Verapamil | 2016 |
A Comparison of Gene Expression of Decorin and MMP13 in Hypertrophic Scars Treated With Calcium Channel Blocker, Steroid, and Interferon: A Human-Scar-Carrying Animal Model Study.
Topics: Adolescent; Adult; Animals; Burns; Calcium Channel Blockers; Child; Child, Preschool; Cicatrix; Cica | 2017 |
Verapamil inhibits interleukin-6 and vascular endothelial growth factor production in primary cultures of keloid fibroblasts.
Topics: Analysis of Variance; Apoptosis; Calcium Channel Blockers; Cell Division; Cells, Cultured; Fibroblas | 2003 |
Prevention and treatment of keloids with intralesional verapamil.
Topics: Adolescent; Adult; Female; Humans; Injections, Intralesional; Keloid; Male; Treatment Outcome; Verap | 2004 |
Treatment of earlobe keloids with surgery plus adjuvant intralesional verapamil and pressure earrings.
Topics: Adolescent; Adult; Calcium Channel Blockers; Child; Ear, External; Female; Humans; Keloid; Male; Mid | 1996 |